Short description
Dermaliq's mission is to develop and sell the next generation of dermatology treatments for patients with severe unmet medical needs.
Description
Dermaliq is developing the next generation of skin care therapies to enhance targeted penetration into skin tissues and to reduce unwanted side effects for millions of patients. The proprietary technology now owned by Dermaliq, called hyliQ™, is designed to allow cutaneous drug delivery with bioavailability. The technology enables the development of effective liquid drug products with exceptional cosmetic properties.
Last funding
Noaccessforu
Sign in for full access
Total funding
$$121212
Sign in for full access
Location
Wilmington, Delaware, United States, North America
Founded on
January 1, 2022
Non-profit?
No
Acquired?
No
Employees count
1-10
Revenue range
$34056 - 789030
Sign in for full access
Investors
Cannot Access, Blurry Noaccess
Sign in for full access
Founders
Betsy Hughes-Formella, Frank Loscher, Oliver Schlüter